Genetic instability of live, attenuated human immunodeficiency virus type 1 vaccine strains
about
Development of dengue virus replicons expressing HIV-1 gp120 and other heterologous genes: a potential future tool for dual vaccination against dengue virus and HIVIntegrase-Deficient Lentiviral Vector as an All-in-One Platform for Highly Efficient CRISPR/Cas9-Mediated Gene EditingStrict control of human immunodeficiency virus type 1 replication by a genetic switch: Tet for Tat.Divergence, not diversity of an attenuated equine lentivirus vaccine strain correlates with protection from diseaseCurrent progress in the development of a prophylactic vaccine for HIV-1.Live attenuated HIV vaccines: predicting the tradeoff between efficacy and safety.Envelope determinants of equine lentiviral vaccine protection.Construction of doxycyline-dependent mini-HIV-1 variants for the development of a virotherapy against leukemiasImmune suppression of challenged vaccinates as a rigorous assessment of sterile protection by lentiviral vaccines.In vitro evolution of a highly replicating, doxycycline-dependent HIV for applications in vaccine studies.Construction of a doxycycline-dependent simian immunodeficiency virus reveals a nontranscriptional function of tat in viral replication.Rift valley fever virus lacking the NSs and NSm genes is highly attenuated, confers protective immunity from virulent virus challenge, and allows for differential identification of infected and vaccinated animals.Evolutionary reversion of live viral vaccines: Can genetic engineering subdue it?Optimization of the doxycycline-dependent simian immunodeficiency virus through in vitro evolutionHuman immunodeficiency virus type 1 subtypes have a distinct long terminal repeat that determines the replication rate in a host-cell-specific mannerIdentification of sequential viral escape mutants associated with altered T-cell responses in a human immunodeficiency virus type 1-infected individual.HIV-1 evolution: frustrating therapies, but disclosing molecular mechanisms.Possible applications for replicating HIV 1 vectorsThe HIV-1 Tat protein has a versatile role in activating viral transcriptionTet-On Systems For Doxycycline-inducible Gene Expression.Modification of the Tet-On regulatory system prevents the conditional-live HIV-1 variant from losing doxycycline-control.Functional differences between the long terminal repeat transcriptional promoters of human immunodeficiency virus type 1 subtypes A through G.Efficient human immunodeficiency virus replication requires a fine-tuned level of transcription.HIV evades RNA interference directed at TAR by an indirect compensatory mechanism.Synthetic biology approach for the development of conditionally replicating HIV-1 vaccine.Improving the safety of a conditional-live human immunodeficiency virus type 1 vaccine by controlling both gene expression and cell entry.HIV-1 Escape From RNAi Antivirals: Yet Another Houdini Action?HIV vaccine: it may take two to tango, but no party time yet.Transmissible Viral Vaccines.Arresting Evolution.A Protocol for the Production of Integrase-deficient Lentiviral Vectors for CRISPR/Cas9-mediated Gene Knockout in Dividing Cells.Intra-host competition between nef-defective escape mutants and wild-type human immunodeficiency virus type 1.Viral attenuation by engineered protein fragmentation.
P2860
Q24797123-CF8D2B7D-5F66-441D-9BF3-6DE332DEFDCBQ33655722-C2246283-8D98-4783-8BBE-715E0BDD90D8Q33835795-48B13BD6-0A11-4C6C-8574-7CC14513B418Q34380211-2ED9F630-4F36-45A3-95DA-3DFD87E519F4Q34502108-06444191-8E73-41B6-A89A-58B895D094EDQ34758133-73324DEF-55BE-4DA4-9015-8904C8F8592BQ34778836-C89FFE2D-2937-4302-B73C-A9972429A229Q35070255-C2682B1A-8E9E-4FCF-9034-A621F2FAD223Q35758001-499AE64D-CAE2-4B47-96B8-1EB663E1F895Q35942568-F2704583-53C5-4907-8426-17A36A925D7AQ36099319-71001AEA-2A1C-40D3-9144-FC4613644479Q36484009-98CACF2E-969A-4FE8-8618-0C337C56E343Q36738542-60096596-3C56-44B2-A3B6-4FB77E450681Q36743410-0126CE6E-0076-403C-B638-8937BD5903FDQ37011027-4004A2E5-DC59-4350-92FA-2DD337B0A09EQ37059821-EF38EF34-0393-4AE4-A62D-E6E26C410EF1Q37755873-2A834910-CEAB-42AE-B956-4E8EFDAD0BFEQ37768033-93052FE1-FBE7-4432-8BDA-8762987897B9Q38286131-EE60F99F-6D98-40AA-9C9C-94309D7F8635Q38842593-9796D1F2-16E2-46A8-81E9-82B27320C5E5Q39136662-E8B3D020-4A0B-44DA-9882-90E06F812D1FQ39590547-4538CF6B-3D0B-4E88-8856-EBE367FB5E9FQ39682784-E4371C67-51A7-409B-A919-7A7AE6C1B441Q39919699-D4DA6DB9-A4D6-4878-9B66-41C7F491D565Q41923238-9DF64442-F5AE-48AC-83D4-21E5F16E74A4Q42104875-985CC1F5-F432-42C8-AB27-36496176B4AFQ42226369-E096037E-52A2-42CD-A874-3E33EC2D7EF3Q42590256-7E101F12-8325-410F-AC32-653143425475Q47443226-7FD2B7EC-498A-4479-9DF0-D292432BA12AQ47446328-B5343ECF-94A6-4BA5-B729-BCDB559CF3DDQ47559748-48309B2B-CCE5-4BBA-94A5-A68E2CCA77C6Q55054068-0D9B22C6-5E12-49E8-BCBE-5ABF15D59C09Q55248625-FD1C6086-9F5E-491F-A7BC-E45DA008CF7C
P2860
Genetic instability of live, attenuated human immunodeficiency virus type 1 vaccine strains
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Genetic instability of live, a ...... y virus type 1 vaccine strains
@en
Genetic instability of live, a ...... virus type 1 vaccine strains.
@nl
type
label
Genetic instability of live, a ...... y virus type 1 vaccine strains
@en
Genetic instability of live, a ...... virus type 1 vaccine strains.
@nl
prefLabel
Genetic instability of live, a ...... y virus type 1 vaccine strains
@en
Genetic instability of live, a ...... virus type 1 vaccine strains.
@nl
P2093
P2860
P1433
P1476
Genetic instability of live, a ...... y virus type 1 vaccine strains
@en
P2093
P2860
P304
P407
P577
1999-02-01T00:00:00Z